Anikó M. Redman
ExxonMobil (United States)(US)
Publications by Year
Research Areas
Melanoma and MAPK Pathways, Chemistry and Chemical Engineering, Steroid Chemistry and Biochemistry, Computational Drug Discovery Methods, Cytokine Signaling Pathways and Interactions
Most-Cited Works
- → Updating and further expanding GSK's solvent sustainability guide(2016)969 cited
- → Development of GSK's acid and base selection guides(2014)124 cited
- → Discovery and SAR of Novel 2,3‐Dihydroimidazo[1,2‐c]quinazoline PI3K Inhibitors: Identification of Copanlisib (BAY 80‐6946)(2016)113 cited
- → Development of GSK's reagent guides – embedding sustainability into reagent selection(2013)105 cited
- → Optimization of 4,6-bis-anilino-1H-pyrrolo[2,3-d]pyrimidine IGF-1R tyrosine kinase inhibitors towards JNK selectivity(2008)58 cited
- → Differential Expression of the Human Somatostatin Receptor Subtypes sst1 to sst5 in Various Adrenal Tumors and Normal Adrenal Gland(2005)54 cited
- → Discovery of a new class of p38 kinase inhibitors(2000)47 cited
- → p38 Kinase inhibitors for the treatment of arthritis and osteoporosis: thienyl, furyl, and pyrrolyl ureas(2001)44 cited
- → Vinylboranes as trans-dihydroxyethylene equivalents for diels-alder reactions(1994)43 cited
- → Preparation of 5-Substituted 3-Aminofuran-2-carboxylate Esters(2000)34 cited